Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS)
Public ClinicalTrials.gov record NCT03919994. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
OASIS: Observational Study of LAIs In Schizophrenia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objectives of this study are to describe characteristics, treatment patterns, and outcomes of patients with schizophrenia newly initiated on 1 of 4 FDA-approved atypical Long Acting Injectable (LAI) antipsychotics (ABILIFY MAINTENA®, ARISTADA®, INVEGA SUSTENNA® or RISPERDAL CONSTA®)
Study identification
- NCT ID
- NCT03919994
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 338 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 28, 2019 (Actual)
- Primary completion
- Jan 4, 2023 (Actual)
- Completion
- Jan 4, 2023 (Actual)
- Last update posted
- Feb 2, 2023
2019 – 2023
United States locations
- U.S. sites
- 57
- U.S. states
- 23
- U.S. cities
- 52
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alkermes Investigational Site | Tucson | Arizona | 85719 | — |
| Alkermes Investigational Site | Costa Mesa | California | 92626 | — |
| Alkermes Investigational Site | El Cajon | California | 92021 | — |
| Alkermes Investigational Site | Granada Hills | California | 91334 | — |
| Alkermes Investigational Site | Oceanside | California | 92054 | — |
| Alkermes Investigational Site | Panorama City | California | 91402 | — |
| Alkermes Investigational Site | San Bernardino | California | 92404 | — |
| Alkermes Investigational Site | Dayville | Connecticut | 06241 | — |
| Alkermes Investigational Site | Hialeah | Florida | 33012 | — |
| Alkermes Investigational Site | Hialeah | Florida | 33016 | — |
| Alkermes Investigational Site | Lauderdale Lakes | Florida | 33319 | — |
| Alkermes Investigational Site | Miami | Florida | 33136 | — |
| Alkermes Investigational Site | Miami Gardens | Florida | 33014 | — |
| Alkermes Investigational Site | Orlando | Florida | 32803 | — |
| Alkermes Investigational Site | Panama City | Florida | 32405 | — |
| Alkermes Investigational Site | Tallahassee | Florida | 32308 | — |
| Alkermes Investigational Site | Augusta | Georgia | 30912 | — |
| Alkermes Investigational Site | Lawrenceville | Georgia | 30046 | — |
| Alkermes Investigational Site | Honolulu | Hawaii | 96817 | — |
| Alkermes Investigational Site | Honolulu | Hawaii | 96826 | — |
| Alkermes Investigational Site | Schaumburg | Illinois | 60194 | — |
| Alkermes Investigational Site | Springfield | Illinois | 62702 | — |
| Alkermes Investigational Site | Indianapolis | Indiana | 46202 | — |
| Alkermes Investigational Site | Bel Air | Maryland | 21015 | — |
| Alkermes Investigational Site | Boston | Massachusetts | 02114 | — |
| Alkermes Investigational Site | Grand Rapids | Michigan | 49503 | — |
| Alkermes Investigational Site | Kalamazoo | Michigan | 49008 | — |
| Alkermes Investigational Site | Kansas City | Missouri | 64108 | — |
| Alkermes Investigational Site | Raymore | Missouri | 64083 | — |
| Alkermes Investigational Site | St Louis | Missouri | 63118 | — |
| Alkermes Investigational Site | St Louis | Missouri | 63128 | — |
| Alkermes Investigational Site | St Louis | Missouri | 63141 | — |
| Alkermes Investigational Site | Lincoln | Nebraska | 68526 | — |
| Alkermes Investigational Site | Manchester | New Hampshire | 03101 | — |
| Alkermes Investigational Site | Buffalo | New York | 14215 | — |
| Alkermes Investigational Site | Glen Oaks | New York | 11004 | — |
| Alkermes Investigational Site | Jamaica | New York | 11418 | — |
| Alkermes Investigational Site | New York | New York | 10032 | — |
| Alkermes Investigational Site | Poughkeepsie | New York | 12603 | — |
| Alkermes Investigational Site | Beachwood | Ohio | 44122 | — |
| Alkermes Investigational Site | Fairlawn | Ohio | 44333 | — |
| Alkermes Investigational Site | Westlake | Ohio | 44145 | — |
| Alkermes Investigational Site | Wooster | Ohio | 44691 | — |
| Alkermes Investigational Site | Durant | Oklahoma | 74701 | — |
| Alkermes Investigational Site | Tulsa | Oklahoma | 74114 | — |
| Alkermes Investigational Site | Tulsa | Oklahoma | 74136 | — |
| Alkermes Investigational Site | Eugene | Oregon | 97401 | — |
| Alkermes Investigational Site | Wyomissing | Pennsylvania | 19610 | — |
| Alkermes Investigational Site | Sioux Falls | South Dakota | 57104 | — |
| Alkermes Investigational Site | Franklin | Tennessee | 37067 | — |
| Alkermes Investigational Site | Austin | Texas | 78746 | — |
| Alkermes Investigational Site | Fort Worth | Texas | 76104 | — |
| Alkermes Investigational Site | Houston | Texas | 77074 | — |
| Alkermes Investigational Site | Richmond | Texas | 77407 | — |
| Alkermes Investigational Site | San Antonio | Texas | 78229 | — |
| Alkermes Investigational Site | Wichita Falls | Texas | 76306 | — |
| Alkermes Investigational Site | Salt Lake City | Utah | 84105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03919994, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 2, 2023 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03919994 live on ClinicalTrials.gov.